Jasper Therapeutics earnings were -$71.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest JSPR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$24.3M, up 30.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JSPR reported annual earnings of -$71.3M, with 10.6% growth. The next JSPR earnings date is May 12, 2025.
Jasper Therapeutics Earnings Reports & History FAQ
What were Jasper Therapeutics's earnings last quarter?
On JSPR's earnings call on Invalid Date, Jasper Therapeutics (NASDAQ: JSPR) reported Q4 2024 earnings per share (EPS) of -$1.64, up 9.33% year over year. Total JSPR earnings for the quarter were -$24.32 million. In the same quarter last year, Jasper Therapeutics's earnings per share (EPS) was -$1.50.
The next JSPR earnings call is Invalid Date. Add JSPR to your watchlist to be reminded of Jasper Therapeutics's next earnings date.
What was JSPR's earnings growth in the past year?
As of Jasper Therapeutics's earnings date in Invalid Date, Jasper Therapeutics's earnings has grown year over year. JSPR earnings in the past year totalled -$71.27 million.
Is Jasper Therapeutics profitable or losing money?
As of the last Jasper Therapeutics earnings report, Jasper Therapeutics is currently losing money. Jasper Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$71.27 million, a 10.55% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.